GSK to Buy Nuvalent for $10.6 Billion in Oncology Push
The acquisition is set to give GSK ownership of three drug candidates for lung cancer, two of which are under FDA review for approval this year.
University Endowments Are About to Strike It Big on the SpaceX IPO
Some schools have a tenth or more of their endowments in Elon Musk's rocket company.
OpenAI Files to Go Public in Test of Investor Appetite for Top AI Startups